tDCS for Treatment Resistant Obsessive Compulsive Disorder

  • STATUS
    Recruiting
  • End date
    Mar 12, 2022
  • participants needed
    100
  • sponsor
    Centre Hospitalier Henri Laborit
Updated on 12 March 2021
transcranial direct current stimulation
antidepressants

Summary

It's a multicentric, randomized, controlled study concerning 100 patients with treatment-resistant obsessive compulsive disorders (OCD). The aim of this study is to evaluate the effect of transcranial direct current stimulation (tDCS) on OCD patients.

Details
Condition Obsessive-Compulsive Disorder, ANXIETY NEUROSIS, Anxiety Disorders (Pediatric), Generalized Anxiety Disorder (GAD), Generalized Anxiety Disorder (GAD - Pediatric), Anxiety Disorders, obsessive compulsive disorder
Treatment sham stimulation, Active stimulation
Clinical Study IdentifierNCT03304600
SponsorCentre Hospitalier Henri Laborit
Last Modified on12 March 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Meets criteria for obsessive compulsive disorder according to Diagnostic and Statistical Manual (DSM IV) with a "good insight" (BABS)
No current depressive and suicidal risks
No epileptic pathology
Age: Participants will be both males and females, 18-70 years of age included
Chronic Obsessive compulsive disorder ( Total Y-BOCS>20 or Y-BOCS one subscale > 15)
Obsessive compulsive disorder resistant to pharmacology treatment
at least 2 antidepressants (IRS type) (> 12 weeks)
cognitive and comportment therapy since at least one year
Treatment stability (antidepressants) for more than 12 weeks without significant improvement
Affiliation to a social security system (recipient or assignee)
Signed written inform consent form

Exclusion Criteria

Female subject who is pregnant, or of child-bearing age, sexually active and not using reliable contraception or who is nursing
Patient under curators
Patient hospitalized under duress
Meets another diagnosis of axe 1 of DSM-IV
Current depressive or suicidal risks
Patient with any form of metal in the cranium, a pacemaker, skull defects, or skin lesions to the scalp (cuts, abrasions, rash)
Epileptic patient
Patient with a medical history of cranial trauma
Patient unable to give his or hers informed consent
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note